In partnership with
The Bottom Line Upfront 💡
Doximity $DOCS ( ▼ 1.63% ) has built the LinkedIn for doctors with 80%+ physician penetration, generating $570M in revenue with 40% operating margins by selling access to this captive audience of medical professionals. The stock appears fairly valued given strong fundamentals, but growth depends on expanding beyond the core physician market.
Sponsorship
How can AI power your income?
Ready to transform artificial intelligence from a buzzword into your personal revenue generator
HubSpot’s groundbreaking guide "200+ AI-Powered Income Ideas" is your gateway to financial innovation in the digital age.
Inside you'll discover:
A curated collection of 200+ profitable opportunities spanning content creation, e-commerce, gaming, and emerging digital markets—each vetted for real-world potential
Step-by-step implementation guides designed for beginners, making AI accessible regardless of your technical background
Cutting-edge strategies aligned with current market trends, ensuring your ventures stay ahead of the curve
Download your guide today and unlock a future where artificial intelligence powers your success. Your next income stream is waiting.
Strata Layers Chart
Layer 1: The Business Model 🏛️
Think of Doximity as the LinkedIn for doctors, but with actual useful features that don't make you want to throw your phone across the room.
What They Actually Do: Doximity built a free professional network for medical professionals that's become the digital town square for America's healthcare workers. Over 2 million medical professionals use the platform - that's 80%+ of U.S. physicians, 60%+ of nurse practitioners, and 90%+ of graduating medical students. It's like they've cornered the market on people who can actually read their own handwriting.
The Money Machine: Here's where it gets clever. While doctors use the platform for free, Doximity makes money by selling access to this captive audience of high-value medical professionals to two main customer groups:
Marketing Solutions 💊: Pharmaceutical companies and health systems pay to deliver targeted, sponsored content to specific groups of doctors. Think "Hey cardiologists, check out this new heart medication" rather than generic drug ads.
Hiring Solutions 🏥: Health systems and medical recruiters pay to post jobs and directly message doctors who might be interested in new positions. Given the massive physician shortage, this is like having a direct line to unicorns.
Workflow Solutions 🔧: Enterprise tools like telehealth (Dialer), scheduling (AMiON), and AI writing assistants that health systems purchase for their entire organizations.
Key Success Metrics: They track customers with $500K+ annual revenue (116 customers, up from 99 ↗️), net revenue retention of 119% ↗️, and over 620,000 active users of their clinical workflow tools. When 95% of your revenue is subscription-based, these retention numbers matter more than your medical school GPA.
The Platform Advantage: Doximity has built something that would be incredibly difficult to replicate - a comprehensive database of physician information combined with HIPAA-compliant tools that actually work in clinical workflows. They've essentially become the digital infrastructure that connects America's fragmented healthcare system.
Key Takeaway: Doximity monetizes the largest network of medical professionals in the U.S. by selling targeted access to pharmaceutical companies and health systems while providing genuinely useful tools to doctors for free.
Layer 2: Category Position 🏆
Doximity sits in a pretty sweet spot - they're the big fish in a specialized pond, rather than a minnow in the ocean of general social media.
The Competition Landscape: While they technically compete with LinkedIn for professional networking and various healthcare IT companies for workflow tools, Doximity's physician-first approach creates meaningful differentiation. LinkedIn has everyone from insurance salespeople to crypto bros; Doximity has people who can actually save your life.
Their real competition comes from:
Market Position: Doximity has achieved something rare in tech - they've built a legitimate moat through network effects in a niche market. With 80%+ physician penetration, they've essentially become the default platform for medical professional networking. It's like being the only decent coffee shop in a medical district - once you're established, it's really hard for competitors to get a foothold.
Recent Wins: Revenue growth accelerated to 20% ↗️ in fiscal 2025, and they're successfully expanding their AI-powered tools with enterprise adoption of Doximity GPT. The fact that they can maintain 90% gross margins while growing this fast suggests their competitive position is strengthening, not weakening.
The Moat: Their competitive advantages are pretty robust - the largest medical professional network, physician-first product design, HIPAA-compliant infrastructure, and proprietary algorithms built on hundreds of millions of member interactions. Good luck replicating that from scratch.
Key Takeaway: Doximity dominates a specialized niche with strong network effects, making it the go-to platform for medical professional networking and a difficult target for competitors to displace.
Layer 3: Show Me The Money! 📈
Doximity's financials are frankly impressive - they've built a business that grows fast, prints cash, and gets more profitable over time. It's like finding a unicorn that also happens to be a cash cow.
Revenue Breakdown: While they don't break out exact segment percentages, subscription revenue represents 95.3% of total revenue ($543.8M of $570.4M). The remaining $26.6M comes from temporary staffing and other services. This subscription dominance provides predictable, recurring cash flows that CFOs dream about.
Growth Story: Revenue has accelerated from 13% growth in fiscal 2024 to 20% ↗️ in fiscal 2025, reaching $570.4M. More importantly, they're demonstrating serious operating leverage - as revenue grows, margins expand dramatically:
Gross margin: 87% → 89% → 90% ↗️
Operating margin: 30% → 35% → 40% ↗️
Net margin: 27% → 31% → 39% ↗️
Customer Economics: Their customer base is both growing and spending more. Customers with $500K+ annual revenue grew from 81 to 116 ↗️, and these big spenders represent 84% of total revenue. Net revenue retention of 119% ↗️ means existing customers are expanding their spending faster than any churn.
Cost Structure: The beauty of this business model is in the cost structure. Once you've built the platform and acquired the network, incremental revenue requires minimal incremental costs:
Cost of revenue: Only 9.8% of revenue (down from 12.8% ↘️)
R&D: 16.3% (focused on product innovation)
Sales & Marketing: 25.5% (down from 29.5% ↘️)
Cash Generation Machine: Operating cash flow hit $273.3M in fiscal 2025 (48% of revenue ↗️), while free cash flow reached $266.7M. They're sitting on $915.7M in cash and marketable securities with essentially no debt. This isn't just profitable - it's "buy back $120M in stock and still have money left over" profitable.
The Margin Expansion Story: What's particularly impressive is how margins have expanded as the business scales. Stock-based compensation is elevated at 12.7% of revenue, but even accounting for that, the underlying unit economics are excellent and improving.
Key Takeaway: Doximity has built a highly scalable, cash-generative business with expanding margins, strong customer retention, and a fortress balance sheet that provides significant strategic flexibility.
Layer 4: Long-Term Valuation (DCF Model) 💰
The Verdict: Fairly Valued to Slightly Undervalued
Key Valuation Drivers:
Network effects and moat quality: 80%+ physician penetration creates sustainable competitive advantages
Subscription model durability: 95%+ recurring revenue with 119% net retention provides cash flow predictability
Operating leverage potential: Margins expanding from 30% to 40%+ demonstrate scalability
Recommendation: The stock appears reasonably valued given the company's strong fundamentals and market position. While the conservative scenario suggests modest downside, the quality of the business model and growth trajectory support the current valuation range.
Layer 5: What Do We Have to Believe? 📚
Bull Case 🚀
Network effects strengthen over time: As more medical professionals join and engage, the platform becomes increasingly valuable to both users and customers, creating pricing power and competitive protection
Successful expansion beyond physicians: Significant growth opportunity in nurse practitioners, physician assistants, and adjacent healthcare professions where penetration remains low
Workflow solutions monetization: Enterprise adoption of AI tools, telehealth, and scheduling solutions represents a large, underpenetrated market with higher revenue per customer potential
Bear Case 🐻
Market saturation limits growth: With 80%+ physician penetration already achieved, user growth may slow significantly, limiting the primary growth driver
Competitive pressure intensifies: LinkedIn, WebMD, or well-funded startups could develop competing platforms that erode Doximity's market position
Healthcare industry disruption: Changes in healthcare delivery, regulation, or physician workflows could reduce platform relevance or monetization opportunities
The Bottom Line: Doximity has built an impressive business with strong competitive positioning and excellent financial metrics. The key question is whether they can successfully expand beyond their core physician network to maintain growth momentum. The current valuation appears reasonable for a company with these fundamentals, but investors need to believe in the company's ability to evolve beyond its current market penetration limits.
What to Watch 👀
Key Metrics to Monitor:
Net revenue retention rate: Watch for any decline below 115% - this would signal customer spending growth is slowing
Customer concentration: Track if the number of $500K+ customers continues growing at 15%+ annually
Workflow solutions adoption: Monitor enterprise customer additions and revenue per enterprise customer trends
Upcoming Catalysts:
AI tool monetization: Success of Doximity GPT enterprise rollout could unlock significant new revenue streams
Adjacent market expansion: Progress in nurse practitioner and physician assistant penetration rates
International expansion: Any moves beyond the U.S. market could dramatically expand the addressable market
Competitive Developments:
LinkedIn healthcare initiatives: Watch for any LinkedIn features specifically targeting medical professionals
Big Tech healthcare moves: Monitor Google, Microsoft, or Amazon healthcare platform developments
Regulatory changes: HIPAA or healthcare privacy regulation changes could impact platform usage or competitive dynamics
Red Flags:
User engagement decline: Any drop in active clinical workflow users below 600K would be concerning
Margin compression: Operating margins declining below 35% would suggest competitive pressure or investment needs
Legal resolution: Outcome of ongoing securities litigation could impact management focus and financial resources
AI-written, human-approved
Disclaimer: This guide is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer or solicitation to buy or sell any securities. The information contained in this report has been obtained from sources believed to be reliable, but StrataFinance does not guarantee its accuracy, completeness, or timeliness.